[1]. Andreasson, U., Perret-Liaudet, A., Van Waalwijk Van Doorn, L. J., Blennow, K., Chiasserini, D., Engelborghs, S., ... & Teunissen, C. E. (2015). A Practical Guide To Immunoassay Method Validation. Frontiers In Neurology, 6, 179.
[2]. Armbruster, D. A., Tillman, M. D., & Hubbs, L. M. (1994). Limit Of Detection (LOD)/Limit Of Quantitation (LOQ): Comparison Of The Empirical And The Statistical Methods Exemplified With GC-MS Assays Of Abused Drugs. Clinical Chemistry, 40(7), 1233-1238.
[3]. Awad, H., El-Sayed, M. M., & El-Lateef, A. E. A. (2021). Recent Advances In The Analysis Of Urine Biomarkers For Clinical And Forensic Toxicology. Microchemical Journal, 164, 106001.
[4]. Chen, Z., & Wang, J. (2005). A Study On The Ultraviolet Spectrum Of Urine And Its Application. Journal Of Biomedical Engineering, 22(3), 589-591.
[5]. Clinical And Laboratory Standards Institute (CLSI). (2014). *EP17-A2: Evaluation Of Detection Capability For Clinical Laboratory Measurement Procedures; Approved Guideline—Second Edition*. CLSI